Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ2RC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,121
Award facts
- Contract value 100% obligated
- $28,121.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,121.25 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL injections on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price, non-set-aside order placed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA and other defense agencies, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Cosentyx, a biologic immunosuppressant used to treat autoimmune conditions, represents one of many specialty pharmaceutical products the company delivers through its DLA prime vendor relationships to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FQ2RC?
SPE2DB25FQ2RC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQ2RC worth?
The government has obligated $28,121 on SPE2DB25FQ2RC.
Is contract SPE2DB25FQ2RC an order under another contract?
Yes. SPE2DB25FQ2RC is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ2RC competed?
The extent of competition for SPE2DB25FQ2RC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award